Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer Disease-Reply.
暂无分享，去创建一个
[1] K. Langa,et al. Preclinical Alzheimer Disease-Early Diagnosis or Overdiagnosis? , 2019, JAMA internal medicine.
[2] M. Carrillo,et al. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia , 2019, JAMA.
[3] J. Birks,et al. Cholinesterase inhibitors for Alzheimer's disease. , 2006 .